WuXi PharmaTech (Cayman) Inc. Deferred Tax Assets, Net of Valuation Allowance
WuXi PharmaTech (Cayman) Inc. had Deferred Tax Assets, Net of Valuation Allowance of $8.14 million as of 2014-12-31, per its 20-F filed 2015-04-15.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2015-04-15
- 2014-12-31: Deferred Tax Assets, Net of Valuation Allowance $8.14M.
- 2013-12-31: Deferred Tax Assets, Net of Valuation Allowance $6.24M.
- 2012-12-31: Deferred Tax Assets, Net of Valuation Allowance $12.09M.
- 2011-12-31: Deferred Tax Assets, Net of Valuation Allowance $13.03M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2014-12-31 | $8.14M 20-F · filed 2015-04-15 |
| 2013-12-31 | $6.24M 20-F · filed 2015-04-15 |
| 2012-12-31 | $12.09M 20-F · filed 2014-04-15 |
| 2011-12-31 | $13.03M 20-F · filed 2013-04-17 |
| 2010-12-31 | $13.87M 20-F · filed 2012-04-20 |